Year To Quarter End Consolidated Statement Of Income

ONO PHARMACEUTICAL CO., LTD. - Filing #7710975

Concept 2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
286,445,000,000 JPY
260,223,000,000 JPY
Cost of sales
80,175,000,000 JPY
62,331,000,000 JPY
Gross profit (loss)
206,270,000,000 JPY
197,892,000,000 JPY
Selling, general and administrative expenses
Salaries
12,021,000,000 JPY
11,679,000,000 JPY
Depreciation
827,000,000 JPY
709,000,000 JPY
Selling, general and administrative expenses
148,473,000,000 JPY
152,355,000,000 JPY
Operating profit (loss)
57,808,000,000 JPY
45,542,000,000 JPY
Non-operating income
Interest income
59,000,000 JPY
29,000,000 JPY
Dividend income
3,092,000,000 JPY
2,900,000,000 JPY
Non-operating income
3,820,000,000 JPY
3,735,000,000 JPY
Non-operating expenses
Interest expenses
22,000,000 JPY
10,000,000 JPY
Non-operating expenses
3,335,000,000 JPY
2,122,000,000 JPY
Ordinary profit (loss)
58,292,000,000 JPY
47,155,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
146,000,000 JPY
2,864,000,000 JPY
Extraordinary income
11,089,000,000 JPY
5,461,000,000 JPY
Profit (loss) before income taxes
69,382,000,000 JPY
52,616,000,000 JPY
Income taxes - current
24,232,000,000 JPY
19,145,000,000 JPY
Income taxes - deferred
-10,582,000,000 JPY
-10,913,000,000 JPY
Income taxes
13,649,000,000 JPY
8,233,000,000 JPY
Profit (loss)
55,732,000,000 JPY
55,732,000,000 JPY
55,732,000,000 JPY
55,732,000,000 JPY
44,383,000,000 JPY
44,383,000,000 JPY
44,383,000,000 JPY
44,383,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.